{"id":116946,"date":"2026-09-03T12:11:33","date_gmt":"2026-09-03T10:11:33","guid":{"rendered":"https:\/\/www.joanneum.at\/?p=116946"},"modified":"2026-09-03T12:31:21","modified_gmt":"2026-09-03T10:31:21","slug":"ausgezeichnete-zusammenarbeit-fuer-lipotrace-nanopartikel-praeziser-analysieren","status":"publish","type":"post","link":"https:\/\/www.joanneum.at\/en\/ausgezeichnete-zusammenarbeit-fuer-lipotrace-nanopartikel-praeziser-analysieren\/","title":{"rendered":"Outstanding collaboration for LIPOTRACE: analysing nanoparticles with greater precision"},"content":{"rendered":"<p class=\"isSelectedEnd\">Nanoparticles play an important role in medicine and the pharmaceutical industry. However, not all particles are the same: rare, particularly large particles or aggregates can affect the safety, efficacy and stability of medicines. In the case of LDL particles, too, their size and chemical composition can provide insights into disease processes such as atherosclerosis.<\/p>\n<p class=\"isSelectedEnd translation-block\">The project <strong>LIPOTRACE<\/strong>, funded by the FFG as part of the Bridge Programme, is therefore developing a novel analytical platform that combines two types of information that were previously separate: the size of individual nanoparticles and their chemical composition.<\/p>\n<p class=\"isSelectedEnd translation-block\">To this end, the project combines the patented <strong>OF2i\u00ae technology from BRAVE Analytics<\/strong> with high-resolution mass spectrometry. A team from the HEALTH Institute contributes expertise in mass spectrometry, BRAVE Analytics provides the OF2i\u00ae technology, and the Medical University of Graz supplies medically relevant samples and medical expertise.<\/p>\n<h2><\/h2>\n<h2>Partnership wins over the cluster community<\/h2>\n<p class=\"isSelectedEnd translation-block\">This collaboration was recognised this summer at the <strong>Cluster Connections 2026<\/strong>: LIPOTRACE won the <strong>CLAUS \u2013 Cluster Award for Unique Synergy<\/strong> from the Human.Technology Styria Cluster. Six collaborative projects were shortlisted for the final, and the cluster community voted LIPOTRACE into first place.<\/p>\n<p class=\"isSelectedEnd translation-block\">The project was presented by <strong>Reingard Raml<\/strong>, overall project manager at JOANNEUM RESEARCH HEALTH, and <strong>Karin Kornm\u00fcller<\/strong> from the Medical University of Graz, who also accepted the award.<\/p>\n<h3><\/h3>\n<h3>Success at the site<\/h3>\n<p class=\"isSelectedEnd\">This success highlights one of LIPOTRACE\u2019s key strengths: three complementary areas of expertise come together at a single research site. Short lines of communication and direct coordination link fundamental research with industrial application.<\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li><a href=\"https:\/\/www.joanneum.at\/health\/en\/projekte\/lipotrace\/\">About the project LIPOTRACE<\/a><\/li>\n<li><a href=\"https:\/\/braveanalytics.eu\/\" target=\"_blank\" rel=\"noopener\">BRAVE Analytics<\/a><\/li>\n<li><a href=\"https:\/\/www.medunigraz.at\/\" target=\"_blank\" rel=\"noopener\">Medical University Graz<\/a><\/li>\n<li><a href=\"https:\/\/www.humantechnology.at\/2026\/06\/26\/sommer-austausch-und-starke-kooperationen\/\" target=\"_blank\" rel=\"noopener\">Cluster Connections 2026, Human Technology Styria: recap and photos<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Nanopartikel spielen in Medizin und Pharmaindustrie eine wichtige Rolle. Doch nicht alle Partikel sind gleich: Seltene, besonders gro\u00dfe Teilchen oder Aggregate k\u00f6nnen Sicherheit, Wirksamkeit und Stabilit\u00e4t von Arzneimitteln beeinflussen. Auch bei LDL-Partikeln k\u00f6nnen Gr\u00f6\u00dfe und chemische Zusammensetzung Hinweise auf Krankheitsprozesse wie Atherosklerose liefern. Das von der FFG im Rahmen des Bridge-Programms gef\u00f6rderte Projekt LIPOTRACE entwickelt [&hellip;]<\/p>\n","protected":false},"author":40,"featured_media":116949,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[5161,5159,5160],"class_list":["post-116946","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-allgemein","tag-forschungskooperation","tag-nanopartikel","tag-pharmaindustrie","institutes-health","business_areas-gesundheit-und-pflege"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.joanneum.at\/en\/wp-json\/wp\/v2\/posts\/116946","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.joanneum.at\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.joanneum.at\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.joanneum.at\/en\/wp-json\/wp\/v2\/users\/40"}],"replies":[{"embeddable":true,"href":"https:\/\/www.joanneum.at\/en\/wp-json\/wp\/v2\/comments?post=116946"}],"version-history":[{"count":5,"href":"https:\/\/www.joanneum.at\/en\/wp-json\/wp\/v2\/posts\/116946\/revisions"}],"predecessor-version":[{"id":116955,"href":"https:\/\/www.joanneum.at\/en\/wp-json\/wp\/v2\/posts\/116946\/revisions\/116955"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.joanneum.at\/en\/wp-json\/wp\/v2\/media\/116949"}],"wp:attachment":[{"href":"https:\/\/www.joanneum.at\/en\/wp-json\/wp\/v2\/media?parent=116946"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.joanneum.at\/en\/wp-json\/wp\/v2\/categories?post=116946"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.joanneum.at\/en\/wp-json\/wp\/v2\/tags?post=116946"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}